Marina Savelieva

Statistics

Publications

Citations

117

H-Index

Active since

2015

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Novartis (India)

Marina Savelieva is an author at Novartis (Switzerland) specializing in pharmacology, clinical pharmacology, and relapsing-remitting multiple sclerosis treatment.

Publications per year

2015–2023

Publications

Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis

Huixin Yu, Gordon Graham, Olivier J. David et al. · CNS Drugs · 2022 · 40 citations · Full text

Pharmacy, Immunology, Pharmacology +17

α4-integrin receptor desaturation and disease activity return after natalizumab cessation

John M. Kovarik, Ludwig Kappos, Marina Savelieva et al. · Neurology Neuroimmunology & Neuroinflammation · 2017 · 35 citations · Full text

Life Sciences, Neuroscience, Pharmacotherapy +17

Population pharmacokinetics of intravenous and oral panobinostat in patients with hematologic and solid tumors

Marina Savelieva, Margaret M. Woo, Horst Schran et al. · European Journal of Clinical Pharmacology · 2015 · 24 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis

Petra Staubach, Montserrat Álvaro‐Lozano, Bülent Enis Şekerel et al. · Pediatric Allergy and Immunology · 2023 · 18 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–4 of 4